PLAYA DEL CARMEN, MEXICO / ACCESSWIRE / November 16, 2023 / Ibogaine By David Dardashti, a leading ibogaine treatment center and research facility, has released the results of a new study that ...
Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Expands access to CN Bio’s robust multi-organ Gut/Liver-on-a-chip model to ...
A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback